Zobrazeno 1 - 4
of 4
pro vyhledávání: '"HELANI (Hellenic Academy of Neuroimmunology)"'
Autor:
Georgios Tsivgoulis, Aristeidis H Katsanos, Dimitris Mavridis, Nikolaos Grigoriadis, Efthymios Dardiotis, Ioannis Heliopoulos, Panagiotis Papathanasopoulos, Theodoros Karapanayiotides, Constantinos Kilidireas, Georgios M Hadjigeorgiou, Konstantinos Voumvourakis, HELANI (Hellenic Academy of Neuroimmunology)
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163296 (2016)
Although Fingolimod (FGD) and Natalizumab (NTZ) appear to be effective in relapsing-remitting multiple sclerosis (RRMS), they have never been directly compared in a randomized clinical trial (RCT).We evaluated the comparative efficacy of FGD vs. NTZ
Externí odkaz:
https://doaj.org/article/ed0cd20841144b60a982bc8f7d566f9d
Autor:
Georgios Tsivgoulis, Aristeidis H Katsanos, Nikolaos Grigoriadis, Georgios M Hadjigeorgiou, Ioannis Heliopoulos, Panagiotis Papathanasopoulos, Constantinos Kilidireas, Konstantinos Voumvourakis, Efthimios Dardiotis, HELANI (Hellenic Academy of Neuroimmunology)
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0144538 (2015)
A number of officially approved disease-modifying drugs (DMD) are currently available for the early intervention in patients with relapsing-remitting multiple sclerosis (RRMS). The aim of the present study was to systematically evaluate the effect of
Externí odkaz:
https://doaj.org/article/b382c3de26c345c9a1ab83200f5be200
Background: Although Fingolimod (FGD) and Natalizumab (NTZ) appear to be effective in relapsing-remitting multiple sclerosis (RRMS), they have never been directly compared in a randomized clinical trial (RCT). Methods and Findings: We evaluated the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::71bdaea869ad4e57e61542c1cfd03939
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3056778
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3056778
Importance: A number of officially approved disease-modifying drugs (DMD) are currently available for the early intervention in patients with relapsing-remitting multiple sclerosis (RRMS). The aim of the present study was to systematically evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::6d925a79a3d9b77fe42bee6f203c002f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3056838
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3056838